News

Archive: 2021

DOD Awards $136.7 Million Contract to MilliporeSigma to Establish Domestic Production Capacity of Critical Material Used in COVID-19 Point-of-Care Tests
December 30, 2021 — On Dec. 29, 2021, the Department of Defense (DOD), on behalf of and in coordination with the U.S. Department of Health and Human Services, awarded a $136.7 million contract to MilliporeSigma to establish nitrocellulose membrane production capacity in the United States. The DOD’s Defense Assisted Acquisition Cell (DA2) led this effort in coordination with the Department of the Air Force’s Acquisition COVID-19 Task Force (DAF ACT) supported by the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) who facilitates the DA2’s Screening & Diagnostics industrial base expansion efforts. This effort was funded through the American Rescue Plan Act (ARPA) to support domestic industrial base expansion for critical medical resources... MORE

Biden Administration Secures 10 Million Courses of Pfizer’s COVID-19 Oral Antiviral Medicine as Additional Tool to Reduce Hospitalizations and Save Lives
November 18, 2021 — As part of its ongoing efforts to curb the pandemic, reduce hospitalizations, and save lives, the Biden Administration has secured 10 million treatment courses of Pfizer’s promising COVID-19 oral antiviral drug, contingent on emergency use authorization (EUA) or approval from the U.S. Food and Drug Administration (FDA)... MORE

American flags against a blue sky background

JPM CBRN Medical Announces RPP in Support of Vaccine Acceleration Program
November 15, 2021 — The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear (CBRN) Defense’s (JPEO-CBRND) Joint Project Manager for CBRN Medical (JPM CBRN Medical), in collaboration with the JPEO-CBRND’s Joint Project Lead for CBRN Defense Enabling Biotechnologies (JPL CBRND EB), and the U.S. Department of Health and Human Services’ (HHS) Biomedical Advanced Research and Development Authority (BARDA), released a request for prototype proposal (RPP) on November 10, 2021, soliciting offers for mRNA vaccine development through December 13, 2021. These offers will include mRNA vaccine design, non-clinical testing, and clinical testing against priority biological threats. ... MORE

JPEO-CBRND Team and Partners Win Five Defense Acquisition Workforce Awards
November 12, 2021 — The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) celebrates its teammates and partners who collectively won five 2021 Defense Acquisition Workforce Awards for their work at the organization... MORE

Winners from the 2021 Defense Acquisition Workforce Award include LTC John Nuckols, Dr. Kevin Wingerd, JPEO-CBRND, U.S. Air Force, COVID-19 USTRANSCOM JUON TC-0003 Response, and U.S. Army, Operation Warp Speed and the JPEO-CBRND Medical Repurposing Team.

CB Defense Today with guest Dr. Jason Roos
November 9, 2021 — CB Defense Today is a quarterly recorded interview, where CBC Director, Dr. Eric L. Moore talks with other leaders across the CB Defense Enterprise. This September Dr. Moore’s guest was Joint Program Executive Officer for CBRND, Dr. Jason Roos. The two discussed the valuable partnership between CBC and JPEO for Chemical, Biological, Radiological and Nuclear Defense, pandemic preparedness in the chemical biological defense space, and improving warfighter protection and decontamination in the field based on future operating environments... MORE

Screenshot of CB Defense Today with guest Dr. Jason Roos

Newly Confirmed Assistant Secretary of Defense, Other DOD Officials Make Inaugural Visit to JPEO-CBRND
November 5, 2021 — Ms. Deborah Rosenblum, the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense Programs (ASD(NCB)) and several other DOD officials visited the headquarters of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear (CBRN) Defense (JPEO-CBRND) at the Aberdeen Proving Ground - Edgewood, Md., on Monday, October 25, 2021. This was Ms. Rosenblum’s first visit to JPEO-CBRND after her Senate confirmation vote on July 29, 2021. ... MORE

DOD Awards Dynavax $22 Million for Plague Vaccine Clinical Trial
November 3, 2021 — The U.S. Department of Defense (DOD) awarded Dynavax Technologies Corporation with an agreement worth approximately $22 million over two and a half years, to execute a clinical trial combining the DOD’s recombinant plague (rF1V) vaccine with its own CpG 1018® adjuvant. Under the agreement, Dynavax will conduct a Phase II clinical trial in 2022. ... MORE

Key Federal Partners Gather to Plan, Act on Emerging CBRN Threats
October 12, 2021 — Efforts to prepare the U.S. military for a series of evolving threats to both the Warfighter and the nation at-large took center stage during the 2021 CBRN Defense Conference and Exhibition in Baltimore, Maryland from August 16-18... MORE

CBRND leadership speak on a panel at the 2021 CBRN Defense Conference

JPM CBRN Medical Provides Relief and Recovery in the Age of a Global Pandemic
October 4, 2021 — The JPM CBRN Medical team is dedicated to mission, warfighter, and Nation. Their work has been instrumental in bringing novel testing capability to the U.S., delivering critical at-home technology necessary to combat the global COVID-19 pandemic. In spearheading the mission of supporting the warfighter, the team indirectly boosted the local economy and remain ready for the next threat, whether intentional or naturally-occurring... MORE

Two uniformed service members are in a tent. One wears PPE and a faceshield, while they use a nasal swab to collect a COVID-19 sample from the other Service member in uniform.

JPM CBRN Medical Provides Relief and Recovery in the Age of a Global Pandemic
September 8, 2021 — What do global pandemic relief efforts, the U.S. Army, and a local Maryland economy have in common? The answer is fearless innovation, the right people in the right place at the right time, and an Australian-based biotech and diagnostic solutions company named Ellume. ... MORE

Aerial photo of Ellume's new Fredrick, MD diagnostics manufacturing facility.

News Search

News Archive - Search by Year and Month

JPEO-CBRND Press Kit

Download our press kit, which includes helpful documents to better understand our work, such as – Command Brief, Chemical Biological Defense Program's Enterprise strategy, the JPEO-CBRND's Capabilities Catalog, Leadership Biographies, COVID-19 fact sheets, and contracting overview documents.

JPEO-CBRND Public Affairs Office

The JPEO-CBRND Public Affairs Office coordinates and responds to all public affairs and media relations needs on behalf of the JPEO-CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office email below.